journal article·2025-03

Subtle structural variations in imidazole-based biomaterials: An experimental and computational investigation

Dhakshinamurthy Divya, Kathiravan Poornima, Venkatesan Srinivasan

Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Mechanical Behavior of Composites · Polymer crystallization and properties · Epoxy Resin Curing Processes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (70)

Show source-provided references
1. Active centre and reactivity descriptor of a green single component imidazole catalyst for acetylene hydrochlorination10.1039/C9CP06005G ↗
2. A mini review: biological significances of nitrogen hetero atom containing heterocyclic compounds
3. Imidazole: synthesis, functionalization and physicochemical properties of a privileged structure in medicinal chemistry10.3390/molecules28020838 ↗
4. Synthesis of imidazole-based medicinal molecules utilizing the van Leusen imidazole synthesis10.3390/ph13030037 ↗
5. Green approaches for the synthesis of poly-functionalized imidazole derivatives: a comprehensive review10.1016/j.crgsc.2021.100175 ↗
6. Ultrafast proton transfer pathways mediated by amphoteric imidazole10.1021/acs.jpclett.3c00595 ↗
7. Imidazole: chemistry, synthesis, properties, industrial applications and biological and medicinal applications
8. Synthesis, characterization, biological applications, and molecular docking studies of some transition metal complexes with azo dye ligand derived from 5-methyl imidazole10.1016/j.molstruc.2023.136695 ↗
9. Anti-fungal effects of novel N-(tert-butyl)-2-(pyridin-2-yl)imidazo[1,2-a]pyridin-3-amine derivative and it's in-vitro, in-silico, and mode of action against Candida spp10.1007/s00203-023-03780-w ↗
10. Synthesis and biological evaluation of novel imidazole derivatives as antimicrobial agents10.3390/biom14091198 ↗
11. Fructose-1,6-bisphosphatase inhibitors: a new valid approach for management of type 2 diabetes mellitus10.1016/j.ejmech.2017.09.029 ↗
12. Imidazoles as potential anticancer agents10.1039/C7MD00067G ↗
13. Synthesis and therapeutic potential of imidazole containing compounds10.1186/s13065-020-00730-1 ↗
14. Gujjarappa · 2022 · 135
15. Monitoring the endocytosis of bovine serum albumin based on the fluorescence lifetime of small squaraine dye in living cells10.1364/BOE.11.000149 ↗
16. Human serum albumin: from molecular aspects to biotechnological applications10.3390/ijms24044081 ↗
17. In silico antiprotozoal evaluation of 1,4-naphthoquinone derivatives against chagas and leishmaniasis diseases using QSAR, molecular docking, and ADME approaches10.3390/ph15060687 ↗
18. An imidazo[1,2-a]pyridine derivative that enables selective and sequential sensing of Cu2+ and CN− ions in aqueous and biological samples10.1002/slct.201903064 ↗
19. Chelation of specific metal ions imparts coplanarity and fluorescence in two imidazo[1,2-a]pyridine derivatives: potential chemosensors for detection of metal ions in aqueous and biosamples10.1016/j.saa.2019.117236 ↗
20. Two imidazo[1,2‐a]pyridine congeners show aggregation‐induced emission (AIE): exploring AIE potential for sensor and imaging applications10.1002/slct.202103408 ↗
21. A 1,8-naphthalimide-based fluorescent sensor with high selectivity and sensitivity for Hg 2+ in aqueous solution and living cells10.1039/C9AY00711C ↗
22. Coordination of distal carboxylate anion alters metal ion specific binding in imidazo[1,2-a]pyridine congeners10.1007/s10895-022-03122-x ↗
23. SYNTHESIS, X-ray crystallography, hirshfeld surface and 3D energy framework analysis of two imidazole derivatives
24. DNA- and BSA-binding studies and anticancer activity against human breast cancer cells (MCF-7) of the zinc(II) complex coordinated by 5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine10.1016/j.saa.2014.02.048 ↗
25. A fluorescent chemosensor for selective detection of chromium (III) ions in environmentally and biologically relevant samples10.1016/j.saa.2024.124286 ↗
26. Coordination of distal carboxylate anion alters metal ion specific binding in imidazo[1,2-a]pyridine congeners10.1007/s10895-022-03122-x ↗
27. The use of quantum chemical methods in corrosion inhibitor studies10.1016/j.corsci.2008.08.043 ↗
28. DFT computational studies, spectroscopic (UV–vis, IR, NMR), in silico molecular docking and ADME study of 3-(3-Methylpyridin-2-yl)-5-phenyl-1,2,4-oxadiazole10.1016/j.molstruc.2023.136724 ↗
29. Interaction of a series of nitriles with the alcohol-inducible isoform of P450: computer analysis of structure—activity relationships10.3109/00498259409043243 ↗
30. Design-based synthesis, molecular docking analysis of an anti-inflammatory drug, and geometrical optimization and interaction energy studies of an indole acetamide derivative10.1016/j.molstruc.2019.127244 ↗
31. Coumarin-benzothiazole based azo dyes: synthesis, characterization, computational, photophysical and biological studies10.1016/j.molstruc.2021.131170 ↗
32. Computational, reactivity, fukui function, molecular docking, and spectroscopic studies of a novel (E)-1-Benzyl-3-(2-(Pyrindin-2-yl)Hydrazono)Indolin-2-One10.1080/10406638.2023.2276241 ↗
33. Miniscule modification of coumarin-based potential biomaterials: synthesis, characterization, computational and biological studies10.1016/j.jphotochem.2023.115044 ↗
34. Coumarin-benzothiazole based azo dyes: synthesis, characterization, computational, photophysical and biological studies10.1016/j.molstruc.2021.131170 ↗
35. Miniscule modification of coumarin-based potential biomaterials: synthesis, characterization, computational and biological studies10.1016/j.jphotochem.2023.115044 ↗
36. Spectroscopic (FT-IR, FT-Raman, NMR and UV–vis), quantum calculation, molecular structure, solvent interaction, ADME and molecular docking investigation on 4-oxo-4h-1-benzopyran-2-carboxylic acid10.1016/j.molstruc.2023.137452 ↗
37. Accurate and cost-effective NMR chemical shift predictions for proteins using a molecules-in-molecules fragmentation-based method10.1039/D0CP05064D ↗
38. Giffonins, antioxidant diarylheptanoids from Corylus avellana , and their ability to prevent oxidative changes in human plasma proteins10.1021/acs.jnatprod.0c01251 ↗
39. A novel isatin-based probe for ratiometric and selective detection of Hg2+ and Cu2+ ions present in aqueous and environmental samples10.1016/j.saa.2020.118796 ↗
40. Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology10.1021/cr040704h ↗
41. Carter · 1994 · 153
42. Binding interaction of quinclorac with bovine serum albumin: a biophysical study10.1016/j.saa.2009.08.018 ↗
43. Spectroscopic analysis on the binding interaction of biologically active pyrimidine derivative with bovine serum albumin10.1016/j.jpha.2015.07.001 ↗
44. Fluorescence chemosensor for anion recognition, solvatochromism and protein binding studies based on Schiff- base derivative10.1016/j.molstruc.2024.138542 ↗
45. Pyrene based Schiff bases: synthesis, crystal structure, antibacterial and BSA binding studies10.1016/j.molstruc.2020.129153 ↗
46. Photophysics and halide quenching of a cationic metalloporphyrin in water10.1039/c3pp50022e ↗
47. Azoimine quinoline derivatives: synthesis, classical and electrochemical evaluation of antioxidant, anti-inflammatory, antimicrobial activities and the DNA/BSA binding10.1016/j.molstruc.2020.128305 ↗
48. Synthesis, single crystal XRD and CT DNA/BSA binding studies of new paracetamol derivatives10.1016/j.molstruc.2020.127911 ↗
49. Study on the binding of colloidal zinc oxide nanoparticles with bovine serum albumin10.1016/j.molstruc.2009.06.032 ↗
50. Spectroscopic studies on the interaction of colloidal capped CdS nanoparticles with bovine serum albumin10.1016/j.colsurfb.2009.03.030 ↗
51. Spectroscopic studies on the interaction between phycocyanin and bovine serum albumin10.1016/j.molstruc.2008.09.005 ↗
52. Interaction of colloidal TiO2 with bovine serum albumin: a fluorescence quenching study10.1016/j.colsurfa.2008.04.017 ↗
53. Exploring the interaction of the photodynamic therapeutic agent thionine with bovine serum albumin: multispectroscopic and molecular docking studies10.1002/bio.2812 ↗
54. Heteroleptic complexes of hydrazone Scaffold of picolinoyl N- oxide and 2,4 dihydroxy phenyl moieties; evaluation of antioxidant activity, DNA and protein binding properties and in vitro antiproliferation studies
55. CB-Dock: a web server for cavity detection-guided protein–ligand blind docking10.1038/s41401-019-0228-6 ↗
56. Synthesis, characterization, and biological activity of some 2,4-diketo esters containing dehydrozingerone fragment: DNA and protein binding study10.1016/j.bmcl.2023.129413 ↗
57. Cytotoxic effect, enzyme inhibition, and in silico studies of some novel N-substituted sulfonyl amides incorporating 1,3,4-oxadiazol structural motif10.1007/s11030-022-10422-8 ↗
58. Novel inhibitors with sulfamethazine backbone: synthesis and biological study of multi-target cholinesterases and α-glucosidase inhibitors10.1080/07391102.2021.1916599 ↗
59. Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: bioactivity, cytotoxicity, and molecular modeling studies10.1016/j.bioorg.2024.107221 ↗
60. In silico antiprotozoal evaluation of 1,4-naphthoquinone derivatives against chagas and leishmaniasis diseases using QSAR, molecular docking, and ADME approaches10.3390/ph15060687 ↗
61. Design, synthesis, and computational studies of novel imidazo[1,2-a]pyrimidine derivatives as potential dual inhibitors of hACE2 and spike protein for blocking SARS-CoV-2 cell entry10.1016/j.molstruc.2023.135525 ↗
62. Design and synthesis of novel enantiopure Bis(5-Isoxazolidine) derivatives: insights into their antioxidant and antimicrobial potential via in silico drug-likeness, pharmacokinetic, medicinal chemistry properties, and molecular docking studies10.1016/j.heliyon.2022.e09746 ↗
63. Modification and characterization of some new levofloxacin heterocyclic derivatives as COX-2 enzyme inhibitors and evaluate their efficacy pharmacokinetics by molecular docking and the Swiss ADME studies10.21123/bsj.2023.8295 ↗
64. Swiss ADME prediction of phytochemicals present in Butea monosperma (Lam.) Taub, ∼ 1799
65. Investigation of the usability of some triazole derivative compounds as drug active ingredients by ADME and molecular docking properties
66. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption10.1021/js9804011 ↗
67. Computer-aided (in silico) modeling of cytochrome P450-mediated food–drug interactions (FDI)10.3390/ijms23158498 ↗
68. In silico evaluation of some 4-(quinolin-2-yl)pyrimidin-2-amine derivatives as potent V600E-BRAF inhibitors with pharmacokinetics ADMET and drug-likeness predictions10.1186/s43094-020-00084-4 ↗
69. SwissADME predictions of pharmacokinetics and drug-likeness properties of small molecules present in Ipomoea mauritiana Jacq, ∼ 2063
70. Shweta